"The Merle M. Mahr Cancer Center at Baptist Health Madisonville is focused on preventing cancer and diagnosing and treating it with the most aggressive, advanced therapies. With state-of-the-art treatments, best-practice therapies and innovative clinal trials, we deliver hope and help to people with cancer."

During the past decade, Baptist Health Madisonville/Merle Mahr Cancer Center conducted 41 clinical trials. In the 10-year time frame, 41 clinical trials started and 26 clinical trials were completed, i.e. on average, 63.4% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 19 clinical trials were completed. i.e. 316.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Baptist Health Madisonville/Merle Mahr Cancer Center" #1 sponsor was "Radiation Therapy Oncology Group" with 38 trials, followed by "National Cancer Institute (NCI)" with 24 trials sponsored, "SWOG Cancer Research Network" with 15 trials sponsored, "Alliance for Clinical Trials in Oncology" with 10 trials sponsored and "NRG Oncology" with 10 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Baptist Health Madisonville/Merle Mahr Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 72 trials as a collaborator, "NRG Oncology" with 8 trials as a collaborator, "North Central Cancer Treatment Group" with 8 trials as a collaborator, "Cancer and Leukemia Group B" with 5 trials as a collaborator and "SWOG Cancer Research Network" with 5 trials as a collaborator. Other collaborators include 19 different institutions and companies that were collaborators in the rest 17 trials.

According to Clinical.Site data, the most researched conditions in "Baptist Health Madisonville/Merle Mahr Cancer Center" are "Recurrent Squamous Cell Lung Carcinoma" (9 trials), "Head and Neck Cancer" (8 trials), "Lung Cancer" (8 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (8 trials) and "Prostate Cancer" (7 trials). Many other conditions were trialed in "Baptist Health Madisonville/Merle Mahr Cancer Center" in a lesser frequency.

Most popular intervention types in "Baptist Health Madisonville/Merle Mahr Cancer Center" are "Drug" (74 trials), "Other" (45 trials), "Radiation" (39 trials), "Procedure" (31 trials) and "Biological" (28 trials). Other intervention types were less common.

The name of intervention was led by "radiation therapy" (31 trials), "Laboratory Biomarker Analysis" (23 trials), "Quality-of-Life Assessment" (14 trials), "Nivolumab" (9 trials) and "conventional surgery" (9 trials). Other intervention names were less common.

The vast majority of trials in "Baptist Health Madisonville/Merle Mahr Cancer Center" are 73 trials for "All" genders, 18 trials for "Female" genders and 6 trials for "Male" genders.

Currently, there are NaN active trials in "Baptist Health Madisonville/Merle Mahr Cancer Center". undefined are not yet recruiting, 10 are recruiting, 26 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 56 completed trials in Baptist Health Madisonville/Merle Mahr Cancer Center, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Baptist Health Madisonville/Merle Mahr Cancer Center, 9 "Phase 1" clinical trials were conducted, 41 "Phase 2" clinical trials and 56 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".